Clinical Trial Update: Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update showing Dolastatin 10 in patients with recurrent or metastatic soft tissue sarcoma has completed; ovarian cancer is listed among the condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• Dolastatin 10 (dolastatin-10)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Cancer, Sarcoma | Phase 2 | Status: COMPLETED